House Joshua

Joshua C.
House is an Executive Vice President at HCRx.
Mr. House, based in San Francisco, is focused primarily on HCRx’s activities on the west coast, including transaction sourcing and structuring.
Prior to joining HCRx, Mr. House was Chief Financial Officer of Hummingbird Bioscience, a clinical-stage antibody platform company focused on oncology and autoimmune disease.
Prior to joining Hummingbird, Mr. House held business development roles at Consonance-HFW Acquisition Corp.
and Atara Biotherapeutics, and was an investment banking Vice President at Citigroup where he covered west coast-based life sciences companies.
During his career in the life sciences industry he has executed equity, M&A and licensing transactions representing over $4 billion in transaction value.
Mr. House holds a B.A.
from Stanford University and J.D.
and M.B.A.
degrees from Columbia University.